Table 2: Effectiveness of maintenance therapy using oral IV ganciclovir in delaying first progression of cytomegalovirus (CMV) retinitis
Cooperative
Study Rachlis
Drew et al(8) Group(10) et al(23)
IV Oral IV Oral IV Oral
Mean time to first progression
of CMV retinitis (days) 62 57 66 54 62 51
Patients with deterioration
of visual acuity(%) 25 20 16 19 11 16
Note: The number of patients in the three studies were 121, 225 and
159; and their median CD4+ counts were 9.5 cells/mm3, 7 cells/mm3 and
10 cells/mm3, respectively.
Return to text